Skip to main content
. 2022 Apr;11(4):835–847. doi: 10.21037/tcr-22-719

Figure 4.

Figure 4

The diagnostic efficiency of serum MAPT-AS1 in BC patients. (A) The diagnostic efficacy of MAPT-AS1 was estimated by ROC curve; (B) the relative expression of serum MAPT-AS1 in BC patients before and after operation. ****, P<0.0001. AUC, area under the curve; ROC, receiver operator characteristic; BC, breast cancer.